Changeflow GovPing Pharma & Drug Safety EPO Patent EP4629967A1: Perfluorinated Micelles...
Routine Notice Added Final

EPO Patent EP4629967A1: Perfluorinated Micelles Medical Uses

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 18th, 2026
Detected March 25th, 2026
Email

Summary

The European Patent Office has published patent application EP4629967A1 concerning perfluorinated micelles and their medical uses. The application lists Commissariat à l'Energie Atomique et aux Energies Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, and Institut National de la Sante et de la Recherche Medicale (INSERM) as applicants.

What changed

This document is a publication of a European patent application (EP4629967A1) related to perfluorinated micelles and their medical applications. The patent application was published on March 18, 2026, with several French research institutions listed as applicants, including Commissariat à l'Energie Atomique et aux Energies Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, and INSERM.

This publication represents the grant of a patent, which provides exclusive rights to the inventors and applicants for their invention. Companies operating in the pharmaceutical or medical device sectors, particularly those involved in drug delivery systems or novel therapeutic agents, should be aware of this patent. While this is a patent grant and not a regulatory rule, it may impact research and development, licensing, and market exclusivity for related technologies within the designated European states.

Source document (simplified)

← EPO Patent Bulletin

PERFLUORINATED MICELLES AND MEDICAL USES THEREOF

Publication EP4629967A1 Kind: A1 Mar 18, 2026

Applicants

Commissariat à l'Energie Atomique et aux Energies
Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche
Medicale (INSERM)

Inventors

DORIS, Eric, GRAVEL, Edmond, GODEL, Sophia, TRUILLET, Charles, PORCEL, Erika, JAMGOTCHIAN, Lucie

IPC Classifications

A61K 9/00 20060101AFI20240614BHEP A61K 9/107 20060101ALI20240614BHEP A61K 41/00 20200101ALI20240614BHEP A61K 51/04 20060101ALI20240614BHEP A61K 51/12 20060101ALI20240614BHEP C07C 323/52 20060101ALI20240614BHEP A61K 47/10 20170101ALI20240614BHEP A61K 47/20 20060101ALI20240614BHEP C08G 65/333 20060101ALI20240614BHEP C08G 65/334 20060101ALI20240614BHEP C08G 65/337 20060101ALI20240614BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

PERFLUORINATED MICELLES AND MEDICAL USES THEREOF

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4629967A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Development Medical Research
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.